Company:  GERON CORP (GERN)
Form Type:  SC 13G/A
Filing Date:  2/17/1998 
CIK:  0000886744 
Address:  149 COMMONWEALTH DRIVE
SUITE 2070
 
City, State, Zip:  MENLO PARK, California 94025 
Telephone:  (650) 473-7700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.03  
Change: 
0.065 (3.32%)  
Trade Time: 
02:35 PM EST  
Market Cap: 
$322.27M
Trade GERN now with 

© 2016  
Description of Business
We are a biopharmaceutical company that currently supports the clinical stage development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies, by Janssen Biotech, Inc., or Janssen. Early clinical data, including molecular responses in essential thrombocythemia, or ET, and remission responses, including reversal of bone marrow fibrosis, in myelofibrosis, or MF, suggest imetelstat may have disease-modifying activity by inhibiting the progenitor cells of the malignant clones for the underlying diseases.
Register and access this filing in:     
  FORM SC 13G/A